Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Construction and validation of a prediction model for postmenopausal asymptomatic endometrial thickening

Published on New Medicine 2025,35(11):1286-1293.
298 times 83 times

XU Yan YANG Tingting MA Chenglei ZHAO Fang MA Xin

Endometrial thickening Risk factors Nomogram Predictive model
Details
The distribution of RhCE phenotypes and molecular genetic background of D variants in preliminary screening of RhD-negative blood donors

Published on New Medicine 2025,35(11):1279-1285.
280 times 89 times

ZHANG Xia ZHAO Gaowei FENG Zhihui GUO Ming

RhD negative RhCE phenotype D variant
Details
Prediction and analysis of red blood cells clinical demand based on the ARIMA model

Published on New Medicine 2025,35(11):1272-1278.
237 times 95 times

YANG Xu LIU Shuqi HUANG Hui CHEN Xiulan LOU Yiling CAO Shiyi JIANG Qingqing

Red blood cell ARIMA multiplicative seasonal model Demand forecasting Health management
Details
Research on the awareness and needs of scientific and technological achievements transformation in tertiary public hospitals in Shanghai

Published on New Medicine 2025,35(11):1265-1271.
249 times 85 times

SUN Lu LI Huiyi SHAN Qiyuan ZHANG Xinyi XU Zengguang

Tertiary public hospitals Technology transfer Transfer awareness Transfer demand Patent transformation
Details
Association of sleep duration and sleep quality with metabolic associated fatty liver disease among Wuhan subway workers

Published on New Medicine 2025,35(11):1256-1264.
232 times 86 times

PENG Rong LIU Junling SHI Bin TAO Yi YAN Xueping HE Zhenyu

Sleep duration Sleep quality Metabolic associated fatty liver disease Mediation effect
Details
Investigation and implementation exploration on knowledge, attitude and practice of influenza vaccination among college students

Published on New Medicine 2025,35(11):1249-1255.
318 times 103 times

XUE Lijia NIE Ying WANG Wei WANG Lu LIU Hongjun LUO Shihuan LI Nan ZOU Xinyu LI Sheyu LUO Li

Influenza Vaccination College students Knowledge attitude and practice Influencing factors
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
323 times 70 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
Anti-infection treatment and pharmaceutical care for a patient with liver cirrhosis complicated with severe psittacosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1340-1346.
427 times 85 times

XING Baiqian LIU Hunan SUN Yihong LU Nianfang LI Zhongdong

Liver cirrhosis Chlamydia psittaci Omadacycline Voriconazole Posaconazole Pharmaceutical care
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
369 times 73 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details
Pharmaceutical care for a case of abemaciclib-induced interstitial lung disease

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1330-1334.
388 times 79 times

DING Liping WU Wei WANG Chunhui

Abemaciclib Interstitial lung disease Breast cancer Pharmaceutical care
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
384 times 74 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
329 times 75 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
324 times 72 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1294-1301.
496 times 88 times

LU Ronghua LIU Jiaojiao PANG Tengfei CAI Rui YUAN Jian

Tegoprazan Gastroesophageal reflux disease Meta-analysis Systematic review Randomized controlled trial
Details
Analysis on the burden and trend of musculoskeletal diseases in China based on GBD 2021

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1283-1293.
371 times 117 times

ZHAO Duowei WEI Jiantong JIANG Jin XU Shenggang ZHANG Hui

Musculoskeletal diseases Gout Osteoarthritis Rheumatoid arthritis Low back pain Neck pain Burden of disease Changing trend
Details
Analysis of the correlation between medication regimen complexity and glycemic control among type 2 diabetes mellitus in the elderly

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1276-1282.
385 times 75 times

ZHI Junna QU Guohong WU Ling TAN Zhen

Medication regimen complexity Elderly Type 2 diabetes mellitus Glycemic control
Details
Insights on facilitators and barriers to regulating non-medical use of prescription opioids: a qualitative study

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1265-1275.
445 times 72 times

DUAN Yuehan ZHOU Huziwei YANG Yingzi WEN Qiaorui CHU Hongling WANG Jingling JIANG Zhiqin SUN Yexiang ZHU Yu WANG Shengfeng

Opioid Non-medical use Drug abuse Substance addiction Drug regulation Qualitative study
Details
Influencing factors for the duration of prophylactic antibacterial therapy in patients with total hip arthroplasty

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1244-1251.
412 times 72 times

FAN Xinxing XIONG Jian LI Lunjin LIU Xiao YANG Zhiyong SHI Zheng

Total hip arthroplasty Antibiotics Prophylaxis Course of treatment Influencing factors
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (11): introduction and examples of pharmacovigilance impact research

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1233-1243.
425 times 137 times

NIE Xiaolu SONG Haibo REN Jingtian YAN Jinan WU Jiarui ZHAN Siyan SUN Feng

Pharmacoepidemiology Methodology Guidelines Pharmacovigilance impact research
Details
Systematic biological study on traditional Chinese medicine treatment for non-alcoholic fatty liver disease: analysis of compatibility patterns and multi-target synergistic mechanisms

Published on Frontiers in Pharmaceutical Sciences 2025,29(11):1878-1886.
1028 times 143 times

ZHANG Zhenwei ZHANG Nana ZHANG Hua SHI Lei YU Qiuxiang

Non-alcoholic fatty liver disease Network pharmacology Molecular mechanism Chemical components of traditional Chinese medicine Collaborative efficiency enhancement
Details